chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 5/8/2021 the next morning 8:00. I noticed a bad headache and had a headache every single day. It was concerning to me because I never get headaches. It lasted a month and I went to see a doctor @ a HCF and they said I could do a cat scan-I was not sure of my cost of that and then another 7-10 days the headaches did disappear. I was prescribe Toradol and it did go away with that but it did come back until it came back but it went away again.
Pt developed sharp pain 6 months after the first Pfizer vaccine. Has went to a neurologist and did an MRI with no success. has also went to a dentist as well.
No adverse effect; PROQUAD was administered to patient via intramuscular; This spontaneous report as received from a nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On 09-AUG-2019, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) injection (dose and frequency was not reported) (lot # S00621, expiry date: 06-JUL-2020) via intramuscular for prophylaxis (incorrect route of product administration). No adverse effects were reported. No product quality complaint was involved.  Lot number [S00621] is an invalid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live.
Muscle soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Muscle soreness at injection site) in a 40-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 15-Sep-2022, the patient experienced VACCINATION SITE PAIN (Muscle soreness at injection site). At the time of the report, VACCINATION SITE PAIN (Muscle soreness at injection site) was resolving.        No concomitant medications were reported.  The patient had no concomitant disease or risk factor.  It was unknown if the patient experienced any additional symptoms and events.  There were no lab data and results available.  No treatment medications were reported.
The patient choked on the Rotarix liquid. He then turned cyanotic and stopped breathing. Patient then took several attempt of patting  and rubbing his back to get him breathing comfortably on his own again.
No adverse events observed or reported.  The intern accidentally gave the Pfizer pediatric dose of 0.2ml when the patient should have received the adult Pfizer dose of 0.3ml.  Patient had turned 12 just 17 days prior on 1/12/2010.
Information has been received from a pharmacist referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On an unknown date the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose and route not reported). On an unknown date the patient experienced a red, hard rash around the unspecified injection site area described as "it was about 3 inches across the injection area and it was getting larger". Outcome of the event was unknown. Causality assessment was not reported. This is one of two reports received from the same reporter. Additional information has been requested.
Indurated with erythema and warm to touch, Keflex 500mg TID q7 days with an ice pack and IBU/Tylenol for pain and inflammation
This case was reported by a healthcare professional and described the occurrence of high fever in a 1-year-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). No information was available regarding concomitant medications, medical history or any adverse events following previous vaccinations. Previous and/or concurrent vaccinations included 10 valent pneumococcal conjugate vaccine; manufacturer unspecified given on an unspecified date; combined diphtheria, tetanus, acellular pertussis and Haemophilus influenzae type b vaccine; manufacturer unspecified given on an unspecified date. On an unspecified date the subject received unspecified dose of PEDIARIX (details unknown). On 12 March 2004, at an unspecified time after vaccination with PEDIARIX, the subject experienced high fever. At the time of reporting the outcome of the event was unspecified. No further information was available.
A few days after the vaccination, patient started shaking his head involuntarily as if he was shaking water out of his ear. I asked my husband to observe and see if he also noticed this. He did. There was no rhyme or reason as to when it would happen. When my husband also observed this behaviour  I immediately called Dr. patient's  pediatrician. My doctor said that patient was probably having seizures and that we should stop vaccinating for now and maybe permanently. He stated that he believed it was a vaccine reaction. I was a wreck. I felt guilty for injuring my son and didn't sleep for days knowing that these seizures may never go away. I stopped observing the head shaking about three weeks after the initial observation. Eight months after that we noticed a huge lump under his mandible. we were referred to a pediatric head and neck doctor. he had labs done and also measured the lump. the blood work came back normal but he did say the size of this lymph node was not normal and that we would have to keep an eye on it. At that moment in time he ruled out cancer because of his labs.it took almost a year for that lump to go back to a normal size.
Glimpse of real madness; psychoactive reaction; Negative emotions; Minor aches like you would have with the flu; This spontaneous case was reported by a consumer and describes the occurrence of MORBID THOUGHTS (Glimpse of real madness), MENTAL DISORDER (psychoactive reaction), INFLUENZA LIKE ILLNESS (Minor aches like you would have with the flu) and NEGATIVE THOUGHTS (Negative emotions) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Drug hypersensitivity.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   In January 2021, the patient experienced INFLUENZA LIKE ILLNESS (Minor aches like you would have with the flu). On 10-Feb-2021, the patient experienced MENTAL DISORDER (psychoactive reaction) and NEGATIVE THOUGHTS (Negative emotions).   On an unknown date, the patient experienced MORBID THOUGHTS (Glimpse of real madness).   At the time of the report, MORBID THOUGHTS (Glimpse of real madness), MENTAL DISORDER (psychoactive reaction), INFLUENZA LIKE ILLNESS (Minor aches like you would have with the flu) and NEGATIVE THOUGHTS (Negative emotions) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
My daughter received a tetanus vaccination at approx. 10:20am on 8-14-06 and complained of severe pain at the shot site. At approx. 6:30am on 8-15-06, she woke feeling ill. She stated she felt sick, hot, and funny. She became dizzy and fell. Ten minutes later she saw "flashes and spots" passed out unconscious on the floor with her eyes open, having mild seizure like symptoms. She became conscious, laid down stating she felt better.
Pain in bones and joints (one day) Migraine headaches (for four days straight) Had to go to emergency room.  No real relief from side effects.  Just had to suffer until it was over which would 4/15/21
fever, couhg, muscle pain, anosmia, can not taste, back pain, tireness
Client states during and after injection she experienced a burning sensation that traveled down from shoulder to her mid arm. Cold water bottle was applied and client was instructed to wait for 15 min minimum for observation. She stated the cold water bottle compress provided some relief after approximately ten minutes at which time she stated the burning was decreased at the injection site but had radiated up to the left side of her neck. Injection site was unremarkable. Client stated "my arm was fine" denied any symptoms and verbalized agreement to go to ER or call 911 for further or additional symptoms.
accidentally given a 0.5 ml dose of Menveo that expired; This case was reported by a physician via sales rep and described the occurrence of expired vaccine used in a adolescent male patient who received Men ACWY-CRM NVS (Menveo) (batch number unknown, expiry date 1st March 2021) for prophylaxis.   On an unknown date, the patient received Menveo .5 ml. On an unknown date, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. On 3rd April 2021 reported that a male adolescent patient was accidentally given a 0.5 ml dose of Menveo that expired on 1st March 2021, which led to Expired vaccine used. No Adverse Event was reported after the patient received the expired Menveo dose. Doctor requested follow up by phone to determine whether another dose of Menveo needs to be re-administered to this patient since the dose which was given expired on 1st March 2021.
pt recvd vax & devel swelling, redness & pain @ the inject site & was feverish for 5 days
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 22-SEP-2015, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 injection (lot# K004483, expiry date 16-AUG-2015; dose and route of administration were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
at approx 1555 02/11/2021 patient had reported to doctor that she was experiencing some scratchiness in the throat in addition to tightness that radiated to her chest. patient further reported that this same reaction had resulted post administration of the first dose of the series. With the first occurrence, it was reported by the patient that she had received a dose of Benedryl PO by a nurse in the office with which she was employed. Patient-reported that that dose of Benedryl had helped the symptoms. Doctor initiated an order at that time for the patient to receive 25mg Benedryl IM, a one-time dose, STAT.  S.K. RN administered the ordered 25mg of benedryl IM via LD at the time of order approx 1558. Pt. is pink, no s/s of SOA/ wheezing, able to speak, respirations noted at 14 Breaths/ min with cap refill 1+.   Patient was monitored post admin with nurses log reading: 02/11/2021 1610: client is eating, drinking, and speaking with ease. pink with no s/s of SOA or hives. throat still feeling a little tight and is a little scratchy.  02/11/2021 1620: Pt. is smiling, speaking, pink and reports throat doesn't feel as tight and throat isn't as scratchy. Doctor walked with patient and assessed lung sounds. no SOA, wheezingor change in pink color when walking. Doctor told patient lungs sounded great and shes fine to go home. Doctor walked patient to car.  02/11/2021 1625: Pt. left clinic and drove self home. refused offer ti be followed home.
This is a 38 year old Nurse who had been in his usual health when he received his anthrax and smallpox vaccinations on 01/29 & 01/30/2003. He states that within a week he developed a dry hacking cough, chest discomfort, fever, chills, body aches and fatigue. He reported to the medical clinic and was treated for a cold. Approximately two (2) weeks after receiving the vaccines he was sent to another location for other activities. He continued to have fever, chills, body aches, chest pain and fatigue. His cough had progressed to a productive cough and he began to have palpitations. He was placed on antibiotics and was given inhalers for his cough. Approximately 3 weeks following vaccination, he was deployed to another country and sent to the front lines in a foreign country. His symptoms continued to progress. His chest discomfort became distinct chest pain that radiated to his left shoulder, scapula, neck and arm. He had increasing dyspnea. He noted that his chest pain and dyspnea improved slightly with leaning forward. He reported to his commander and was medivaced back to the field hospital in a foreign country. At the field hospital he underwent serial ECGs which reportedly revealed diffuse ST segment elevations. His echocardiogram revealed some "enlargement" of his heart with visualization of "free fluid". He remained in the hospital for approximately five (5) days and was returned to limited duty in a foreign country. After returning to duty, he continued to have chest pain and increasing dyspnea and fatigue. He was once again returned to the field hospital where he was re-evaluated. He continued to have diffuse ST segment elevation on ECG. His echocardiogram revealed a decrease in amount of fluid, but an increasing left ventricular wall thickness. It was determined that he should be transferred to a hospital. He was transferred by Medivac. At hospital he was admitted to the intensive care unit where he remained until discharge five (5) days later. At hospital he underwent laboratory, radiological and cardiac evaluation which revealed elevated cardiac enzymes, a "top-normal" cardiac silhouette on xray and left ventricular wall thickness on echocardiogram. Upon discharge he was returned where he resumed his nursing duties. In the almost two (2) years since the onset of his symptoms, this service member has gradually increased his exercise tolerance. He continues to have some exertional dyspnea and chest tightness when running greater than 1-1.5 miles. He also experiences palpitations on exertion. He has had no follow-up since his last stress echocardiogram in June 2003 which revealed No left ventricular regional wall motion abnormalities at baseline or peak activity; no chest pain or arrhythmias were noted. However on echocardiogram he did demonstrate an increased left ventricular wall thickness.
Itchy, swollen skin around eyes, face, ears, neck, under left breast, and arms.
3PM unconsolable crying pt taken to MD 330PM; 5PM pt began having sz action & stopped breathing, mom rushed pt to ER pt admitted; dx anaphylatic shock; cyanotic, wheezing, SOB, croupy cough & congestion, acidotic, loose watery stool; etc
7/4/22  I started passing out. I went to the doctor and had bloodwork done which showed I was low in Iron, B12 and WBC.  I was given a B12 infusion and Iron infusion.
This is a spontaneous report from a contactable physician received via Pfizer sales representative. A female patient (age 45-50, Unit unknown) of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration at single dose in the left deltoid on an unspecified date. The patient medical history and concomitant medications were not reported. The patient developed an abscess and cellulitis after 1 week of administration on unknown date. Antibiotic treatment was needed for 1 week. The abscess and cellulitis were resolved after antibiotic treatment.
vision was off and even confusion; vision was off and even confusion; dizzy; showed the lymph nodes were inflamed; got hives; arm swelled; This is a spontaneous report from a contactable consumer. A 49-years-old male patient received first dose of BNT162B2 (Formulation: Solution for injection, Batch/Lot Number: ER8735), via an unspecified route of administration, administered in Arm Left on 16May2021 10:00 AM as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history included drug allergy to penicillin from an unknown date and unknown if ongoing. COVID-19 from an unknown date and unknown if ongoing. The patient concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and sertraline hydrochloride (ZOLOF) taken for an unspecified indication, start and stop date were not reported. The patient was diagnosed with COVID-19 prior to vaccination and not diagnosed since the vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received shot on Sunday May 16th at 10 am, slept for 23 or 24 hours and would not eat or drink, second day better but arm swelled and got hives gave Benadryl and missed two day of work went back on Wednesday then on May 23rd, woke up dizzy and vision was off and even confusion, went to ER and started stroke protocol, did all testing including a chest x-ray that showed the lymph nodes were inflamed, kept treating as if a possible stroke, MRI machine down so they admitted and waited for machine next day was released after negative scan. The adverse event result in emergency room/department or urgent care. The patient received treatment with adverse event all testing for stroke protocols. Seriousness criteria was Caused/prolonged hospitalization. Since the vaccination, the patient has not been tested for COVID-19. The patient underwent lab tests and procedures which included chest x-ray: lymph nodes were inflamed on 23May2021, magnetic resonance imaging: negative scan on 23May2021, sars-cov-1 test positive: positive on an unspecified date. On an unspecified date, the events were resolved.
Lymph node swelling and cold severe fluid build up in ear on 16 Feb 2012 went to the doctor was given antibiotic for sinusitis. March 6 2012: elbow inflammation and severe pain had to go to the ER. Was suspected bursitis, continued visit to orthopaedic in 2 days. Blood test was ordered Creactive protein was elevated and a cast was put though xray was normal. Next day a rheumatologist asked me to visit cast was removed elbow fluid take no infection was found just inflammation. My leg was swollen by March 18 2012 and elbow started receding on its own. Since I was alone I was forced to resign my job and return home for diagnosis. They have found here its reactive arthritis due to the vaccination and I am still recovering. I am to undergo physiotherapy to regain my elbow movement.
Left thigh was red, swollen, and hot to the touch. Mom noticed the redness and swelling  on Saturday when the patient woke up.  Patient came in our office today and his leg was still swollen but not as much as Saturday.
Information has been received from a Registered Nurse concerning a 20ish year old female who was vaccinated with the first dose of Gardasil.  Concomitant therapy included 2 other vaccines (unspecified).  Subsequently the patient fainted after receiving the vaccines.  The patient recovered and was fine after about 20-30 minutes.  Medical attention was sought.  Additional information has been requested.
"Patient started therapy with PNEUMOVAX 23 for pneumonia. Patient experienced swelling."; "Patient started therapy with PNEUMOVAX 23 for pneumonia.; This spontaneous report was received from a consumer and refers to a male patient. The patients' medical history, concurrent conditions, concomitant therapies were not provided.  On an unknown date, the patient started therapy with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, administered for pneumonia (strength, dose description, lot number, expiry date, and route of administration were not provided) (product use in unapproved indication).  On an unknown date, the patient experienced swelling. The outcome of the event was reported as unknown.  The causal relationship between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and swelling was not provided.
Muscle pain, slight fever, joint pain very week or tired. Kept me in bed for 24 hours. This did not happen with the first dose.
pt received shot at 9:30 am and experience normal side effects of chills, achy around 10 pm Wednesday am she started nausea and drive heaves.  Her sister in law called her on the phone and she reports she was unable to talk.  she knew what she wanted to say, but unable to get the words out.  Reports she recovered quickly.  Event lasted about 15 mins.  Did not seek treatment.
patient reports blurred vision and light headed. Vitals stable. patient asked to lay down with legs elevated. cold water given patient became fine in 15 minutes
At 1630 pt c/o tightness and tongue swelling. Administered benadryl 50mg PO and cetirizine 10mg PO  Pt taken to private observation room, reclined and VS taken WNL Extension of sx to include repetitive cough, throat secretions, anxiety, expiratory wheezes epinephrine 0.3mg IM  x1 administered at 1645, 2L O2 by NC applied for comfort; and EMS activated VS taken again and WNL Stable on discharge at 1705 and sent to nearest ER by ambulance
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22May2022 as dose 3 (booster), single (Lot number: FK9894) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "lupus" (unspecified if ongoing); "Known allergies: penicillin" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYCHLOROQUINE, start date: Sep2011; VITAMIN D NOS; GLUCOSAMINE AND CHONDROITIN.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Indication=Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti-viral details: Product: COVID 19 Treatment, Brand: Paxlovid, Treatment start date: 13Sep2022, Lot number: GE1671, Indication: Treatment of COVID-19. The patient previously receive a COVID-19 Vaccine. The patient taken other medications/products within 2 weeks of starting COVID-19 treatment. Device Date : 14Sep2022.  No follow-up attempts are possible. No further information is expected.
Within a few minutes of the vaccine I developed itchiness, tightness, difficulty breathing, coughing, couldn't move air properly etc
Pt received TDap on 3/31/10.  She had peeling on soles of feet and hands, N/V, fever, and diarrhea.  These symptoms started after she received vaccine and lasted for about 1 week.  Skin exfoliation has improved, but still present over 3 months later.